{"id":"https://openalex.org/W4405226984","doi":"https://doi.org/10.1080/14712598.2024.2438740","title":"An evaluation of pozelimab for the treatment of CHAPLE disease","display_name":"An evaluation of pozelimab for the treatment of CHAPLE disease","publication_year":2024,"publication_date":"2024-12-10","ids":{"openalex":"https://openalex.org/W4405226984","doi":"https://doi.org/10.1080/14712598.2024.2438740","pmid":"https://pubmed.ncbi.nlm.nih.gov/39657032"},"language":"en","primary_location":{"id":"doi:10.1080/14712598.2024.2438740","doi":"https://doi.org/10.1080/14712598.2024.2438740","is_oa":false,"landing_page_url":"https://doi.org/10.1080/14712598.2024.2438740","pdf_url":null,"source":{"id":"https://openalex.org/S57380513","display_name":"Expert Opinion on Biological Therapy","issn_l":"1471-2598","issn":["1471-2598","1744-7682"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Biological Therapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5051321436","display_name":"Salim Can","orcid":"https://orcid.org/0000-0003-3797-3001","observed_orcids":["https://orcid.org/0000-0003-3797-3001"]},"institutions":[{"id":"https://openalex.org/I74897591","display_name":"Marmara University","ror":"https://ror.org/02kswqa67","country_code":"TR","type":"education","lineage":["https://openalex.org/I74897591"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Salim Can","raw_affiliation_strings":["Division of Allergy and Immunology, Department of Pediatrics, School of Medicine, Marmara University, Istanbul, Turkey","Istanbul Jeffrey Modell Diagnostic Center for Primary Immunodeficiency Diseases, Istanbul, Turkey","The Isil Berat Barlan Center for Translational Medicine, Istanbul, Turkey"],"raw_orcid":"https://orcid.org/0000-0003-3797-3001","affiliations":[{"raw_affiliation_string":"Division of Allergy and Immunology, Department of Pediatrics, School of Medicine, Marmara University, Istanbul, Turkey","institution_ids":["https://openalex.org/I74897591"]},{"raw_affiliation_string":"Istanbul Jeffrey Modell Diagnostic Center for Primary Immunodeficiency Diseases, Istanbul, Turkey","institution_ids":[]},{"raw_affiliation_string":"The Isil Berat Barlan Center for Translational Medicine, Istanbul, Turkey","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078101142","display_name":"Melek Yorgun Altunba\u015f","orcid":"https://orcid.org/0000-0002-4832-2928","observed_orcids":["https://orcid.org/0000-0002-4832-2928"]},"institutions":[{"id":"https://openalex.org/I74897591","display_name":"Marmara University","ror":"https://ror.org/02kswqa67","country_code":"TR","type":"education","lineage":["https://openalex.org/I74897591"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Melek Yorgun Altunbas","raw_affiliation_strings":["Division of Allergy and Immunology, Department of Pediatrics, School of Medicine, Marmara University, Istanbul, Turkey","Istanbul Jeffrey Modell Diagnostic Center for Primary Immunodeficiency Diseases, Istanbul, Turkey","The Isil Berat Barlan Center for Translational Medicine, Istanbul, Turkey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Allergy and Immunology, Department of Pediatrics, School of Medicine, Marmara University, Istanbul, Turkey","institution_ids":["https://openalex.org/I74897591"]},{"raw_affiliation_string":"Istanbul Jeffrey Modell Diagnostic Center for Primary Immunodeficiency Diseases, Istanbul, Turkey","institution_ids":[]},{"raw_affiliation_string":"The Isil Berat Barlan Center for Translational Medicine, Istanbul, Turkey","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111245909","display_name":"Ahmet Oguzhan Ozen","orcid":"https://orcid.org/0000-0002-9065-1901","observed_orcids":["https://orcid.org/0000-0002-9065-1901"]},"institutions":[{"id":"https://openalex.org/I74897591","display_name":"Marmara University","ror":"https://ror.org/02kswqa67","country_code":"TR","type":"education","lineage":["https://openalex.org/I74897591"]}],"countries":["TR"],"is_corresponding":true,"raw_author_name":"Ahmet Ozen","raw_affiliation_strings":["Division of Allergy and Immunology, Department of Pediatrics, School of Medicine, Marmara University, Istanbul, Turkey","Istanbul Jeffrey Modell Diagnostic Center for Primary Immunodeficiency Diseases, Istanbul, Turkey","The Isil Berat Barlan Center for Translational Medicine, Istanbul, Turkey"],"raw_orcid":"https://orcid.org/0000-0002-9065-1901","affiliations":[{"raw_affiliation_string":"Division of Allergy and Immunology, Department of Pediatrics, School of Medicine, Marmara University, Istanbul, Turkey","institution_ids":["https://openalex.org/I74897591"]},{"raw_affiliation_string":"Istanbul Jeffrey Modell Diagnostic Center for Primary Immunodeficiency Diseases, Istanbul, Turkey","institution_ids":[]},{"raw_affiliation_string":"The Isil Berat Barlan Center for Translational Medicine, Istanbul, Turkey","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5111245909"],"corresponding_institution_ids":["https://openalex.org/I74897591"],"apc_list":null,"apc_paid":null,"fwci":0.4633,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.58719895,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":96},"biblio":{"volume":"25","issue":"1","first_page":"1","last_page":"7"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10993","display_name":"Complement system in diseases","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10993","display_name":"Complement system in diseases","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11917","display_name":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11725","display_name":"Immunodeficiency and Autoimmune Disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/c5-inhibitor","display_name":"C5 inhibitor","score":0.7889999747276306},{"id":"https://openalex.org/keywords/protein-losing-enteropathy","display_name":"protein-losing enteropathy","score":0.9010000228881836},{"id":"https://openalex.org/keywords/systemic-thrombosis","display_name":"systemic thrombosis","score":0.8820000290870667},{"id":"https://openalex.org/keywords/anti-complement-therapy","display_name":"anti-complement therapy","score":0.8169999718666077},{"id":"https://openalex.org/keywords/infection-risk","display_name":"infection risk","score":0.5669999718666077},{"id":"https://openalex.org/keywords/vaccination","display_name":"vaccination","score":0.40400001406669617},{"id":"https://openalex.org/keywords/antibiotic-prophylaxis","display_name":"antibiotic prophylaxis","score":0.9229999780654907},{"id":"https://openalex.org/keywords/rare-diseases","display_name":"rare diseases","score":0.45500001311302185}],"concepts":[{"id":"https://openalex.org/C2778426112","wikidata":"https://www.wikidata.org/wiki/Q3055380","display_name":"Enteropathy","level":3,"score":0.6535146236419678},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6340993642807007},{"id":"https://openalex.org/C2777991916","wikidata":"https://www.wikidata.org/wiki/Q421617","display_name":"Eculizumab","level":4,"score":0.6136153340339661},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.5514720678329468},{"id":"https://openalex.org/C112313634","wikidata":"https://www.wikidata.org/wiki/Q7886648","display_name":"Complement (music)","level":5,"score":0.5128848552703857},{"id":"https://openalex.org/C111684460","wikidata":"https://www.wikidata.org/wiki/Q334848","display_name":"Complement system","level":3,"score":0.5098146796226501},{"id":"https://openalex.org/C2779931649","wikidata":"https://www.wikidata.org/wiki/Q416510","display_name":"C1-inhibitor","level":3,"score":0.4408387839794159},{"id":"https://openalex.org/C2777637130","wikidata":"https://www.wikidata.org/wiki/Q17165460","display_name":"Atypical hemolytic uremic syndrome","level":4,"score":0.4404504597187042},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.425538569688797},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.36459726095199585},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.26317107677459717},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.23304465413093567},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.19357815384864807},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.17746326327323914},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.12097111344337463},{"id":"https://openalex.org/C127716648","wikidata":"https://www.wikidata.org/wiki/Q104053","display_name":"Phenotype","level":3,"score":0.08480685949325562},{"id":"https://openalex.org/C188082640","wikidata":"https://www.wikidata.org/wiki/Q1780899","display_name":"Complementation","level":4,"score":0.0},{"id":"https://openalex.org/C2777995640","wikidata":"https://www.wikidata.org/wiki/Q1129007","display_name":"Angioedema","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003182","descriptor_name":"Complement C5","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D003182","descriptor_name":"Complement C5","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1080/14712598.2024.2438740","doi":"https://doi.org/10.1080/14712598.2024.2438740","is_oa":false,"landing_page_url":"https://doi.org/10.1080/14712598.2024.2438740","pdf_url":null,"source":{"id":"https://openalex.org/S57380513","display_name":"Expert Opinion on Biological Therapy","issn_l":"1471-2598","issn":["1471-2598","1744-7682"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Biological Therapy","raw_type":"journal-article"},{"id":"pmid:39657032","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/39657032","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert opinion on biological therapy","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320325078","display_name":"Marmara \u00dcniversitesi","ror":"https://ror.org/02kswqa67"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":21,"referenced_works":["https://openalex.org/W1970764349","https://openalex.org/W2004265876","https://openalex.org/W2130599966","https://openalex.org/W2178334364","https://openalex.org/W2724335952","https://openalex.org/W2733091118","https://openalex.org/W2899629480","https://openalex.org/W2904264587","https://openalex.org/W2905688330","https://openalex.org/W2988291220","https://openalex.org/W3023414123","https://openalex.org/W3088822708","https://openalex.org/W3104000830","https://openalex.org/W3120574198","https://openalex.org/W3153432228","https://openalex.org/W3211756270","https://openalex.org/W4220878524","https://openalex.org/W4310161929","https://openalex.org/W4386116681","https://openalex.org/W4389146491","https://openalex.org/W4391127258"],"related_works":["https://openalex.org/W7140221626","https://openalex.org/W4381516631","https://openalex.org/W4394688795","https://openalex.org/W4391127258","https://openalex.org/W4386155811","https://openalex.org/W7203632062","https://openalex.org/W4401272427","https://openalex.org/W4387764680","https://openalex.org/W4380091168","https://openalex.org/W4409859847"],"abstract_inverted_index":{"INTRODUCTION:":[0],"CHAPLE":[1,63,125],"disease":[2,126],"is":[3],"a":[4,43,73,119,128],"severe,":[5],"ultra-rare":[6],"disorder":[7],"caused":[8],"by":[9,38],"CD55":[10],"gene":[11],"mutations,":[12],"leading":[13],"to":[14,47,81,117],"uncontrolled":[15],"complement":[16,40,97],"hyperactivation,":[17],"protein-losing":[18],"enteropathy,":[19],"and":[20,59,76,92,109,136,142,163,176,194],"systemic":[21],"thrombosis.":[22],"Recent":[23],"advances":[24],"in":[25,149],"targeted":[26,131],"therapies,":[27],"particularly":[28],"the":[29,55,178,187],"C5":[30,74],"inhibitor":[31],"pozelimab":[32,135,146],"(Veopoz),":[33],"offer":[34],"new":[35],"treatment":[36,192],"options":[37],"addressing":[39],"dysregulation,":[41],"marking":[42],"shift":[44],"from":[45,78,114],"symptomatic":[46],"precision":[48],"therapy.":[49,182],"AREAS":[50],"COVERED:":[51],"This":[52],"review":[53],"explores":[54],"pathophysiology,":[56],"clinical":[57],"manifestations,":[58],"current":[60],"treatments":[61],"for":[62,180],"disease.":[64],"It":[65],"examines":[66],"pozelimab's":[67],"pharmacological":[68],"development,":[69],"its":[70],"mechanism":[71],"as":[72,161],"inhibitor,":[75],"results":[77],"Phase":[79,82],"1":[80],"3":[83],"studies.":[84],"Additionally,":[85],"potential":[86],"use":[87],"of":[88,130,186],"other":[89],"anti-C5":[90],"therapies":[91,133],"emerging":[93],"agents":[94],"targeting":[95],"proximal":[96],"components":[98],"are":[99],"discussed.":[100],"A":[101],"systematic":[102],"literature":[103],"search":[104],"using":[105],"PubMed,":[106],"Google":[107],"Scholar,":[108],"ClinicalTrials.gov":[110],"focused":[111],"on":[112,170],"studies":[113],"2017":[115],"onwards":[116],"provide":[118],"comprehensive":[120],"overview.":[121],"EXPERT":[122],"OPINION:":[123],"Managing":[124],"requires":[127],"combination":[129],"anti-complement":[132],"like":[134,154],"supportive":[137],"measures,":[138,159],"including":[139],"nutritional":[140],"support":[141],"thrombosis":[143],"management.":[144],"While":[145],"shows":[147],"promise":[148],"reversing":[150],"core":[151],"symptoms,":[152],"risks":[153],"serious":[155],"infections":[156],"necessitate":[157],"preventive":[158],"such":[160],"vaccination":[162],"antibiotic":[164],"prophylaxis.":[165],"Future":[166],"research":[167],"should":[168],"focus":[169],"optimizing":[171],"dosing,":[172],"evaluating":[173],"long-term":[174],"safety,":[175],"assessing":[177],"need":[179],"lifelong":[181],"Expanding":[183],"our":[184],"understanding":[185],"disease's":[188],"pathophysiology":[189],"will":[190],"refine":[191],"strategies":[193],"improve":[195],"outcomes.":[196]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2024-12-11T00:00:00"}